The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Clindamycin Phosphate
Clindamycin Phosphate USP, 1% · CLINDAMYCIN PHOSPHATE 10 mg/g · Gel · Topical · A-S Medication Solutions
NDC 50090-5958-00 · 1 TUBE in 1 CARTON / 30 g in 1 TUBE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for clindamycin phosphate (other) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- A-S Medication Solutions LLCUnited Statesrelabel
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA212438
- TE code
- AB1
- Approval date
- Mar 11, 2021
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Clindamycin Phosphate USP, 1% (Gel)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| A-S Medication Solutions | CLINDAMYCIN PHOSPHATE 10 mg/g | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Clindamycin Phosphate — NDC 50090-5958-00," retrieved September 3, 2026, https://drugdashboards.com/drug/50090595800.
Free to cite with attribution — see how the data is put together.